Information:
Fel:
Nyckelord
Register ×
- COVID-19 (31)
- Lymphoma, Non-Hodgkin (30)
- Medical History Taking (25)
- Follow-Up Studies (21)
- Routine documentation (19)
- Neurology (17)
- Stroke (14)
- Cardiology (14)
- Neoplasms (14)
- Cardiovascular Diseases (13)
- Pediatrics (13)
- Sweden (12)
- Brain Injuries (12)
- Psychiatry (11)
- Bipolar Disorder (11)
- Documentation (11)
- Emergency Medical Services (11)
- Medical Oncology (11)
- Multiple Sclerosis (11)
- Myelodysplastic Syndromes (9)
- Breast Neoplasms (8)
- Leukemia (8)
- Ophthalmology (8)
- AML (7)
- Anemia, Sickle Cell (7)
- Quality of Life (6)
- Cerebral Palsy (6)
- Pandemics (6)
- Proposed Standard (6)
- GMDS-Challenge (6)
- Urology (5)
- Interview (5)
- Acute Coronary Syndrome (5)
- Emergency protocol (5)
- Health Services Research (5)
- Anesthesiology (5)
- Rehabilitation (4)
- Urinary Bladder Neoplasms (4)
- Critical Care (4)
- Glaucoma (4)
- Hematology (4)
- Mortality (4)
- Myocardial Infarction (4)
- Patient Admission (4)
- Physical Examination (3)
- Back Pain (3)
- Mammaplasty (3)
- Cardiopulmonary Resuscitation (3)
- Intensive Care (3)
- Disease Management (3)
- Physical Therapy Specialty (3)
- Stem Cell Transplantation (3)
- Cataract (3)
- CML (3)
- Adverse event (3)
- Registration (3)
- Baseline (3)
- Treatment Form (3)
- CLL (3)
- Eligibility Determination (3)
- Emergency Treatment (3)
- Patient Care (3)
- Craniocerebral Trauma (3)
- Lymphoma (3)
- Mastectomy (3)
- Postoperative Complications (2)
- Risk Factors (2)
- Scoliosis (2)
- General Surgery (2)
- Surgical Procedures, Operative (2)
- Therapeutics (2)
- Glasgow Coma Scale (2)
- Bone Marrow Transplantation (2)
- Caregivers (2)
- Neck Pain (2)
- Hormone Replacement Therapy (2)
- Vital Signs (2)
- Perioperative Period (2)
- Organ Dysfunction Scores (2)
- Patient Outcome Assessment (2)
- Visual Analog Scale (2)
- Response Evaluation Criteria in Solid Tumors (2)
- Common Data Elements (CDE) (2)
- Anticoagulation (2)
- Released Standard (2)
- Diagnosis (2)
- Disability Evaluation (2)
- Emergency Medicine (2)
- Epidemiology (2)
- Exercise Test (2)
- Family Planning Services (2)
- Alzheimer Disease (2)
- Geriatrics (2)
- Heart (2)
- Heart Failure (2)
- Anesthesia (2)
- Laboratories (2)
- Myeloproliferative Disorders (2)
- Nephrology (2)
Innehållsförteckning
Valda datamodeller
Du måste vara inloggad för att välja flera datamodeller, ladda ner dem eller analysera dem.
305 Sökresultat.
Item-grupper: ANTIBODIES IN THE PATIENT, PRE-TRANSPLANT HISTORY OF DOCUMENTED INVASIVE FUNGAL INFECTION SINCE INITIAL DIAGNOSIS, PERFORMANCE SCORE, DONOR AND STEM CELL SOURCE, HLA MISMATCHES BETWEEN DONOR AND PATIENT, BLOOD GROUP, DATE OF BIRTH AND SEX OF DONOR, STATUS OF THE DONOR OR CORD BLOOD UNIT BEFORE HSCT, HISTOCOMPATIBILITY RESULTS, DNA (Allelic/molecular) HLA typing done, Serology (antigenic) HLA typing done, GRAFT MANIPULATION, CELL INFUSION, CELL VIABILITY RESULTS AT HSCT CENTRE, CELLS INFUSED FROM THIS DONOR AND STEM CELL SOURCE COMBINATION, HSC TRANSPLANTATION, PREPARATIVE TREATMENT (conditioning), Drugs, TREATMENT DURING THE IMMEDIATE POST-TRANSPLANT PERIOD, Number of cells infused by type, Total number of cells infused, GRAFT PERFORMANCE, DATE(S) AND RESULTS OF ALL TESTS DONE FOR ALL DONORS, ACUTE GRAFT VERSUS HOST DISEASE (GvHD), COMPLICATIONS WITHIN THE FIRST 100 DAYS., STATUS AT 100 DAYS, Method of detection, LAST DISEASE STATUS, ADDITIONAL NOTES IF APPLICABLE, ALLOGRAFT APPENDIX
Item-grupper: Patient information, Anamnesis status, Laboratory, Mutations
Comorbidity
1 Item-grupp 27 Dataelement Item-grupper: 3-month Follow-up, General information, RIKSSTROKE – 3-month Follow-Up Questionnaire
Item-grupper: Acute Phase for Registration of Stroke - Personal Information, Sequence of care, Aftercare, ADL/Accommodation BEFORE ONSET of stroke, Risk Factors Stroke, Acute Care/Diagnosis Stroke, Pharmaceutical Treatment, Thrombolysis, Thrombectomy, Hemicraniectomy, Information and Follow-up, Rehabilitation
Item-grupp: RIKS-STRROKE - 2 YEARS FOLLOW-UP
Item-grupper: Administrative Data, Demography, Risk Factors, Quality of Life, Medical History, Clinical features, Investigation, Diagnosis, Therapy
Item-grupper: Finding ocular Right Eye, Finding ocular Left eye
SECTION 1: PATIENTS DEMOGRAPHY AND MEDICAL HISTORY
1 Item-grupp 14 DataelementSECTION 2: OCULAR FINDINGS DURING REFERRAL
2 Item-grupper 11 Dataelement Item-grupper: Emergency Anamnesis, Medication Anamnesis, Prehospital emergency Medication, Medical condition leading to Emergency Room contact, Patient Basic Clinical Data, Multiple Drug Resistence, Allergies
Patient information
4 Item-grupper 17 DataelementDiagnoses, Therapy, additional Information
12 Item-grupper 55 DataelementDiagnostics
16 Item-grupper 46 DataelementVital signs and scores
6 Item-grupper 16 Dataelement Item-grupper: Patient administration, Medical History, Anticoagulation, platelet aggregation inhibitors or anti-imflammatories in medial history
Item-grupper: General Information, GENERAL INFORMATION, GENERAL INFORMATION, BONE MARROW FAILURE SYNDROME (INCLUDING APLASTIC ANAEMIA), SUBCLASSIFICATION, CYTOGENETICS, HAEMATOLOGICAL VALUES, COMPLICATIONS, PNH TESTS, FIRST IMMUNOSUPPRESSIVE TREATMENT EPISODE, IF 1ST TREATMENT EPISODE FOR THE PATIENT EVER, IF PATIENT HAS BEEN TREATED BEFORE, ADDITIONAL IMMUNOSUPPRESSIVE TREATMENT EPISODE, STATUS AT HSCT, ADDITIONAL TREATMENT POST-HSCT, BEST DISEASE RESPONSE AT 100 DAYS POST-HSCT, FORMS TO BE FILLED IN
Item-grupper: GENERAL INFORMATION, Patient, DISEASE, CLINICAL FEATURES AND COMPLICATIONS, STATUS OF DISEASE AT HSCT, Enzymes, LIVER FUNCTION, RESULTS OF LIVER BIOPSY, CARDIAC FUNCTION, ADDITIONAL TREATMENT POST-HSCT, FORMS TO BE FILLED IN
Item-grupper: Administrative data, Symptoms at initial diagnosis, Comorbidity at initial diagnosis, Comorbidity Follow up, Laboratory at initial diagnosis, Laboratory follow-up, Follow up, Disease progression, Blood cell morphology, Cellular Morphology Bone marrow, Histology Bone Marrow, Molecular Genetics, secondary myelodysplastic syndromes, Therapy Myelodysplastic syndrome, Treatment